Insulin resistance: site of the primary defect or how the current and the emerging therapies work. [electronic resource]
- Journal of basic and clinical physiology and pharmacology 1998
- 281-94 p. digital
Publication Type: Journal Article; Review
0792-6855
10.1515/jbcpp.1998.9.2-4.281 doi
Adipose Tissue--drug effects Appetite Depressants--therapeutic use Diabetes Mellitus, Type 2--drug therapy Female Fenfluramine--therapeutic use Humans Hypoglycemic Agents--therapeutic use Imidazoles--agonists Insulin Resistance--physiology Ligands Metformin--therapeutic use Thiazoles--therapeutic use Thiazolidinediones